The World Health Organization released updated guidelines on reducing the risk of cognitive decline and dementia in July 2026. The document is useful for one reason in particular: it treats brain health as more than a puzzle of supplements, memory games, or one ideal diet.
It also creates an opening for a conversation we tend to avoid.
Risk reduction is not a guarantee.
That sounds obvious. It is not how much brain-health marketing works. We are routinely handed the implication that, if we identify enough “modifiable” factors and manage them correctly, we can engineer a particular future for our brains.
We cannot.
We can make better judgments about what deserves attention. That is a different claim, and a more honest one.
What the new guidance gets right
The updated WHO guidance takes a life-course view. It considers health behaviors, conditions associated with higher risk, environmental exposures, and multidomain approaches rather than presenting cognitive decline as the consequence of one isolated habit.
That matters because the brain is not separate from the rest of the body. Its energy demands are high. It depends on reliable blood flow, glucose regulation, sleep, oxygen delivery, nutrient adequacy, and the integrity of blood vessels. Vascular disease, diabetes, untreated hearing loss, smoking, heavy alcohol use, inactivity, poor sleep, and social or environmental conditions can all belong in a brain-health conversation for good reason.
But belonging in the conversation does not mean each factor carries the same weight. It does not mean the evidence is equally strong. And it certainly does not mean a person’s outcome can be traced back to one choice.
Here is the part worth looking at: the guideline itself identifies areas where evidence remains insufficient. That should not be seen as a failure. It is a necessary boundary around what a guideline can honestly claim.
Mechanism is not the same as outcome
Brain health often gets explained through plausible biology. Better cardiovascular health may support blood flow to the brain. Better glucose regulation may reduce some metabolic strain. Sleep is involved in memory consolidation and has connections to vascular and metabolic health. Physical activity can affect blood pressure, insulin sensitivity, fitness, and inflammation.
Those mechanisms matter. They help explain why a factor might be relevant.
But a plausible mechanism is not proof that changing one behavior will prevent dementia, preserve memory indefinitely, or reverse an established disease process.
That distinction becomes especially important when someone is selling a narrow intervention. A supplement may affect a biomarker. A wearable may identify fragmented sleep. A food may contain compounds relevant to inflammation or vascular function. None of that automatically demonstrates a meaningful long-term cognitive benefit in people who are otherwise well nourished, sleeping adequately, or already receiving appropriate medical care.
I keep coming back to this question: what outcome was actually measured?
Was it a laboratory marker? A short cognitive test? Daily function? Diagnosed dementia? A finding can be interesting without being a reason to make large promises about a person’s future brain.
Why single-factor thinking fails
It is tempting to look for the most important lever. Is it sleep? Resistance training? Protein? Omega-3 fats? Blood sugar? Menopause treatment? Cognitive training?
The answer is often unsatisfying: it depends on the person, the baseline problem, the exposure, the timing, and the outcome being discussed.
For someone with uncontrolled hypertension, vascular health may be the most relevant brain-health issue in the room. For another person, untreated sleep apnea may deserve more attention than an expensive cognitive supplement. For someone with restrictive eating, nutrient adequacy may matter more than optimization. For an older adult with emerging frailty, preserving strength, mobility, and cardiovascular capacity may be more meaningful than trying to perfect a “brain diet.”
This is why generalized lists can be both useful and misleading. They identify domains worth considering. They cannot rank every domain correctly for every individual.
The American Heart Association made a related point in its April 2026 scientific statement on brain health across the life span: brain health is shaped by physical health, psychological health, environment, sleep, social conditions, and access to care over time. That is a broader and more realistic frame than personal optimization alone.
Modifiable does not mean fully controllable
The language of modifiable risk has value. It tells us that biology is not destiny and that prevention is not pointless.
But it can become distorted into a moral category. If risk is modifiable, then a poor outcome can be made to look like evidence that someone failed to manage life correctly.
That is not what the science says.
Genetics matter. Age matters. Disease processes can begin long before symptoms are obvious. Access to food, safe spaces for movement, stable housing, medical care, time, money, education, air quality, and treatment for chronic conditions all shape what is realistically modifiable. Some exposures are easier to identify than to change.
Even the strongest prevention research deals in probabilities across groups. It does not offer an individual contract.
A better way to read brain-health claims
When a brain-health claim comes across your screen, it helps to sort it into a few categories:
- Established health relevance: Does this factor clearly matter for cardiovascular, metabolic, or overall health, even if its precise cognitive effect is less certain?
- Direct evidence: Has an intervention been shown to improve a meaningful cognitive or functional outcome, not just a mechanism or surrogate marker?
- Baseline context: Is the proposed benefit most plausible for people with a deficiency, disease, low fitness level, poor sleep, or another identifiable starting problem?
- Tradeoffs: What are the financial, physical, social, and opportunity costs of making this the main project?
- Certainty: Are we looking at a strong conclusion, a reasonable inference, or an interesting hypothesis?
New guidelines do not give us a formula for preventing dementia. They give us a better map of the terrain, including where the evidence is solid and where it is still incomplete.
That may be the most useful way to think about brain health: not as a score to maximize, but as a long-term effort to notice what is actually affecting the conditions under which the brain has to function.
Written for Dr. Teralyn Sell, PhD
Psychology · Brain Health · Human Behavior